Atıf Formatları
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Goker And A. Biray, "The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.," Cytokine & growth factor reviews , 2020

Goker, B. And Biray, A. 2020. The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.. Cytokine & growth factor reviews .

Goker, B., & Biray, A., (2020). The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.. Cytokine & growth factor reviews .

Goker, BAKİYE, And Avci Biray. "The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.," Cytokine & growth factor reviews , 2020

Goker, BAKİYE G. And Biray, Avci. "The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.." Cytokine & growth factor reviews , 2020

Goker, B. And Biray, A. (2020) . "The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.." Cytokine & growth factor reviews .

@article{article, author={BAKİYE GÖKER BAĞCA And author={Avci Biray}, title={The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.}, journal={Cytokine & growth factor reviews}, year=2020}